Founded in 2014, Prenetics is a major global diagnostics and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars — Prevention, Diagnostics and Personalized Care — comprehensive and accessible to anyone, at anytime and anywhere. Prenetics is led by visionary entrepreneur, Danny Yeung, with operations across 9 locations, including United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. Prenetics develops consumer genetic testing and early colorectal cancer screening; provides COVID-19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing. Most recently on May 18th 2022, Prenetics made international headlines to become Hong Kong’s First Unicorn to publicly list on the Nasdaq with ticker symbol of “PRE”. ——————————— PODCAST ——————————— 🎙 Check out the What The FinTech Podcast. Spotify Apple Podcast Google Podcast ——————————— CONNECT ——————————— 🎯 LinkedIn: https://www.linkedin.com/in/medhysouidi/ Twitter: @medhy_souidi ——————————— WATCH ——————————— Youtube: https://www.youtube.com/c/WhatTheFinTech Twitch: https://www.twitch.tv/medhy_s ——————————— SOCIAL MEDIA ——————————— Telegram: https://t.me/WTFintech Instagram: https://www.instagram.com/wtf_fintech/ Facebook: https://www.facebook.com/wtfintech Main Site: www.wtf-fintech.com WTF Linkedin Page: https://www.linkedin.com/company/wtf-fintech/ WTF Twitter Page: @wtf_fintech #FinTech #Innovation #Podcast #wtf #wtf_fintech #whatthefintech #medhysouidi 🎙️ Host: Medhy Souidi

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related